Understanding the National List of Essential Medicines (NLEM) Revision

The National List of Essential Medicines (NLEM) is a list published by the Government of India, specifically by the Ministry of Health and Family Welfare. This list includes medicines considered essential for addressing the priority healthcare needs of the majority of the population.

The question focuses on the revision of the NLEM that took place in September 2021. During this revision, the government made changes to the existing list by both adding new drugs and removing some older ones.

Details of the September 2021 NLEM Revision

In the September 2021 revision of the National List of Essential Medicines (NLEM), the Government of India took significant steps to update the list to reflect current health priorities and available treatments. This involved a careful review of existing medicines and consideration of new drugs.

Based on the revision, a specific number of new drugs were added to the list, making them more accessible and affordable for the public. Simultaneously, some drugs were also removed from the list, often due to reasons such as the availability of better alternatives, concerns about safety, or lack of efficacy for priority conditions.

The exact number of drugs added during this particular revision is a key detail. The revision aimed to ensure that the NLEM remains a relevant and effective tool for guiding public health policies and procurement decisions.

During the September 2021 revision, the number of drugs added to the National List of Essential Medicines was 39.

Revision Table: NLEM Changes (September 2021)

Additional Information: Importance of NLEM

The NLEM plays a crucial role in the healthcare system of India. Its importance stems from several factors:

• Accessibility and Affordability: Medicines on the NLEM are typically included under price control mechanisms by the National Pharmaceutical Pricing Authority (NPPA), making them more affordable for the general public.
• Rational Use of Medicines: The list promotes the rational use of medicines by prioritizing drugs based on disease prevalence, efficacy, safety, and cost-effectiveness.
• Procurement Policies: State governments and public health programs often use the NLEM as a basis for their drug procurement policies, ensuring essential medicines are available in public health facilities.
• Guidance for Doctors: It serves as a guide for doctors on which medicines are considered essential for various health conditions.
• Training and Education: The NLEM is often used in medical and pharmaceutical training curricula.

The process for revising the NLEM involves experts from various fields, including clinicians, pharmacologists, epidemiologists, and health economists, ensuring that the list is updated based on the latest scientific evidence and public health needs.